showed a trendP value = 0.09
A similar trend was also observed in Tempus OS that IFNγ scores showed a trend of favorable OS outcomes only in PD-L1 high subgroups (HR = 0.63, P value = 0.09 for PD-L1 ≥50% vs.
A similar trend was also observed in Tempus OS that IFNγ scores showed a trend of favorable OS outcomes only in PD-L1 high subgroups (HR = 0.63, P value = 0.09 for PD-L1 ≥50% vs.
In investigating the association between ceramide levels and Ki-67 index within each individual patient, ceramide in cancer tissue showed a trend toward a negative association (R 2 =0.05) with levels of Ki-67 index ( p =0.09) (Figure 7C ).
ING subjects also showed a trend toward more ischemic-type collapse compared to DN patients (36.4% vs. 0%, p = 0.090) (Table 2 ).
Uploads of blood glucose levels ( n = 189) showed a trend toward improvement with each additional 10 uploads associated with an estimated 0.4% reduction in GHb ( P = 0.09).
However, pancreatic duct dilation and lymph node (LN) metastasis showed a trend toward poorer survival, with a HR of 3.728 (95% confidence interval [CI] 0.815–17.053; p = 0.090) and 4.369 (95% CI, 0.858–22.233; p = 0.076), respectively ( Table 4 ).
While Cox regression did not reveal statistically significant associations with graft survival, CD3 − PAX8 − CD16 + CD57 + cells showed a trend toward increased risk (HR = 2.73, p = 0.09).
Moreover, the conformity index (CI) showed a trend toward significantly better in the 2-ARC compared to the other techniques ( p = 0.09) Table 1 .
Higher EVD volumes showed a trend to more secondary infarctions ( p = 0.09), whereas higher LD volumes were associated with less secondary infarctions ( p = 0.009).
CV-ST was significantly increased in the har40 (p = 0.02) and showed a trend in wei40 (p = 0.09) compared to the normg trials.
We found that rats injected with the miR-cluster showed a trend toward higher numbers of Ki67 and BrdU-positive nuclei in hepatocytes compared to their respective controls (P = 0.09 and 0.07, respectively).
Patients with high FGFR1 expression and/or FGFR1 amplification showed a trend toward poorer OS compared to those without these alterations (P=0.09; Figure 5 ).
Weight showed a trend (OR = 2.8; p = 0.09; 95% CI 0.99-1.04).
The active arm showed a trend toward enhanced healing over placebo ( p = 0.09) [ 31 ] ( Table 10 ).
Contrasts between angry and neutral sentences failed to reach significance but showed a trend into the same direction (F(1, 22) = 3.18, p = .09).
Nulliparity showed a trend toward association (aOR = 1.481, 95% CI 0.940–2.332, p = 0.090) but did not reach statistical significance.
We also found the frequencies of S 614G variant showed a trend of positive correlation with fatality rates ( r = 0.54, P = 0.090; Fig. 4b ) in BCG-vaccinated countries, but such correlation was not observed in BCG-non-vaccinated countries ( r = 0.19, P = 0.47; Fig. 4b ).
Nonetheless, in the intention-to-treat population, Impella showed a trend toward lower rates of MAE in the per-protocol population (34% vs 42%; P = .09) and lower rates of 90-day MAE (40% vs 51%; P = .023). 64 A recent prespecified, retrospective analysis by race of the PROTECT II trial showed similar rates of MAE at 90 days between White and non-White patients (40.9% and 44.5%; P = .53). 66 The ongoing Impella-Supported PCI in High-Risk Patients with Complex CAD and Reduced Left Ventricular Function trial (PROTECT IV), 67 may provide further information regarding the use of MCSD in racial/ethnic minorities with reduced EF undergoing high risk PCI.
At comparable procedure durations (MDCT: 217±74 min, EVM: 194±57 min, p=0.15) the MDCT group showed a trend towards shorter mapping times (MDCT: 42±18 min, EVM: 49±13 min, p=0.09), particularly in cases with non-ischemic cardiomyopathy (NICM) (MDCT: 41±20 min, EVM: 54±15 min, p=0.07).
Additionally, the MPR/pCR group showed a trend toward longer DFS (P=0.09) ( Figure 2F ).
Patients in the acute stage showed a trend towards elevated T2 values (p = 0.09), and had the highest T2 values (58 and 60 ms, respectively).
For the three fROIs that were more active for R Hits > K Hits ( Table 2 ), two (in left and right inferior parietal cortex) showed a significant interaction between Priming Type and Prime Status [ F (1,17) s > 5.3, p s < .05], while the third (in posterior cingulate cortex) showed a trend in the same direction [ F (1,17) = 3.27, p = .09].
Higher QMSD showed a trend towards increased k w in the final model (β = 0.558, p = 0.090) ( Table 3 ). 4.
The addition of elotuzumab to Vd in a phase II clinical trial showed a trend towards increased OS and PFS (median, 9.7 vs. 6.9 months, p = 0.09) but did not reach statistical significance [ 107 ].
REM-OSA showed a trend toward higher prevalence in the narcolepsy group compared to controls (26.4% vs 17.2%, OR: 1.73, 95% CI: 0.91–3.27, p = 0.09).
Post hoc group comparisons demonstrated that this difference found in the Mph-treated ADHD group differed significantly from the TD group [ F (1,32) = 7.3, p < 0.05, η 2 = 0.19], and showed a trend towards a difference in the Mph-free ADHD group [ F (1,30) = 3.1, p = 0.09, η 2 = 0.10].